Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation

BACKGROUND: Mutations in the TERT promoter, ALK rearrangement, and the BRAF V600E mutation are associated with aggressive clinicopathologic features in thyroid cancers. However, little is known about the impact of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diagn Pathol
Autors principals: Bae, Ja Seong, Kim, Yourha, Jeon, Sora, Kim, Se Hee, Kim, Tae Jung, Lee, Sohee, Kim, Min-Hee, Lim, Dong Jun, Lee, Youn Soo, Jung, Chan Kwon
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746931/
https://ncbi.nlm.nih.gov/pubmed/26857243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0458-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars